COVID 19: The death of many famous Chinese figures is a public issue

COVID 19: The death of many famous Chinese figures is a public issue

KUALA LUMPUR: The sudden increase in the number of deaths among famous figures in China has caused a large number of people there to question the official death toll due to COVID-19.

Citing the BBC , people began to dispute the official number of deaths due to COVID 19 after the death of famous opera singer, Chu Lanlan, last month.

However, the cause of the sudden death of the 40-year-old soprano singer was not revealed to the public.

According to Operawire , Chu Lanlan is a talented singer of Peking Opera , which is an art theater where performers perform through speech, song, dance and battle movements to tell stories including performances for charity.

Besides Chu Lanlan, Gong Jintang’s sudden death also shocked the people of China. The 83-year-old actor was reported dead on January 1.

Gong’s name became famous after his appearance in China’s longest-running TV drama series In-Laws, Out-laws . The cause of his death is still unclear but netizens associate it with the death of an elderly person the same age as the actor.

Meanwhile, former journalist and retired professor from Nanjing University, Hu Fuming, 87, reportedly died on January 2.

At the same time, the death of the famous screenwriter Ni Zhen, 84, is also the talk of the people in China. He is famous for his work in the film Raise the Red Lantern which was released in 1991.

Last month, China relaxed its ‘Zero-Covid-19’ policy after it suddenly abolished the zero-Covid-19 policy which saw a sharp increase in cases.

There are reports that hospitals and crematoriums are becoming overcrowded following the increase in cases.

China no longer announces the number of victims and daily cases of COVID-19 throughout the republic since the end of last December.

The National Health Commission (NHC) announced the latest move thus ending the practice that has been in place since early 2020.

Share This


Wordpress (0)
Disqus (0 )